A one-day Lonza symposium in Shanghai, to gain insight and discuss

Thursday 12 November 2020 | Renaissance Shanghai Zhongshan Park Hotel
 

Lonza is pleased to invite you to join us for a complimentary symposium on Thursday 12 November 2020 at the Renaissance Shanghai Zhongshan Park Hotel, 1018 Changning Road, Shanghai to gain insight from experts, in the different approaches and techniques to successfully progress therapeutic proteins from discovery to the clinic. Hear about updates on enhancements to new and established technologies enabling translational research. The day includes talks from industry experts, local biotech companies and technical specialists from Lonza. Our networking and lunch breaks offer the opportunity to speak with fellow scientists, presenters and Lonza specialists. During the symposium, you will have the opportunity to book 1-on-1 Virtual Clinics with Lonza scientific experts.

Registration

Attendance at this event is complimentary and by invitation.

Registration has closed.


Agenda (China standard time)

8.30  – 9.00 Delegate Registration, Networking over Tea and Coffee
9.00 – 9.20 Welcome and Introduction | Overview of Lonza's biologics services and China focus
Jeff Li | General Manager, Greater China, Lonza
9.20 – 9.30 Agenda and overview
9:30 – 10.00 Upstream challenges and Strategies for Antibody-based Therapeutic Development
Dr. Jizu Yi | SVP, Wuhan YZY Biopharma
10.00 – 10.30 A step forward – combined strategies to enhance the performance of Pichia pastoris 
Dr. Joachim Klein | Head of Strain Development and Cell Banking, Microbial Development Services, Lonza
10.30 – 11.00 The challenges of bi-specific for CMC and forward looking
Dr. Karen Twu | CMC Head, Harbour BioMed
11.00 – 11.15
Break
11.15 – 11.45
Major considerations when collaborating with CDMO
Peter Wang, VP CMC Head, Elpiscience Biopharmaceuticals
11.45 – 12.15
Lonza Biosciences Solutions products and services for cell therapy
Dr. Dandan Zhong | Product Marketing Manager, Bioscience Solutions, Lonza
12.15 – 13.00
Lunch
- Virtual clinics start at 15.00
13.00 – 13.30

Therapeutic antibody drugs development based on VHH structural combination
Dr. Huang Yanshan | Founder/CEO of Zhejiang Doer Biotechnology Co., Ltd.

13.30 – 14.00 Developability assessment tools and de-risking strategies to support progression of biologics from discovery to development
Dr. Yvette Stallwood | Head, Applied Protein Services, Lonza 
14.00 – 14.20 Break
- Virtual clinics start at 15.00
 14.20 – 15.00 Approaches to maximise successful development of cell lines expressing a diverse range of proteins - including bispecific antibodies
Dr. Alison Porter | Head of Expression System Sciences, Lonza
 15.00 – 16.00 Networking Drinks and Snacks
- Virtual clinics start at 15.00
 16.00 Delegates depart
 16.00 – 17.30 Virtual clinics continue for those involved

Venue details:  The Symposium will take place at: Renaissance Shanghai Zhongshan Park Hotel - 1018 Changning Road, Shanghai.


Registration has closed.